Peptide Decoding
New?New to peptides?Start here →
Decoding

Cartalax_Dosage, benefits & legal status

Also known as AED, Ala-Glu-Asp

Published July 22, 2026 · Updated August 14, 2026

A bioregulator for cartilage and joint health, with thin evidence.

Joint / cartilageBioregulator peptideResearch only
Common vial size20 mg
DoseVaries (course-based)
FrequencyCourses
RouteUnder the skin (subcutaneous)
StatusResearch only
CycledCourses of 10 to 20 days, repeated two or three times a year

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is Cartalax?

Plain language first. The technical label stays, but it never stands alone.

Overview

It is marketed for cartilage and joint health, but there is very little real human research behind it.

The technical version

Cartalax is a 3-amino-acid 'bioregulator' from the Russian Khavinson family.

What it's used for

A bioregulator aimed at cartilage and joint health, taken in short courses.

02

How does Cartalax work?

What it does in the body, and where.

Cartalax is three amino acids, marketed for cartilage and joint tissue.

  1. 01
    The claim is cartilage support
    On the Khavinson premise that short peptides act selectively on the tissue they were derived from.
  2. 02
    No citable human evidence
    Its Russian-language studies are in cartilage tissue models rather than in people with joint disease.
Anatomical illustration highlighting tendons-joints
WHERE THIS COMPOUND IS THOUGHT TO ACT:
CartilageJoint

03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Cartilage and joint healthResearch only

The published record

Research index

0

Papers and trials about Cartalax

Searched: Cartalax.

Left out: AED (too short to disambiguate without context); Ala-Glu-Asp (two or three residue sequence, matches generic peptide chemistry).

Europe PMC was searched on 25 October 2026 for these terms and returned nothing.

Counted from Europe PMC indexing, not read by a person.

Cartalax vial rendering
Compound field notes

At a glance

Four things to know about Cartalax

01

Evidence

Research only

02

Category

Healing and recovery

03

Common vial

20 mg

04

Half-life

Nothing published

04

How much, and do you cycle it?

The range, and whether you take breaks.

Varies (course-based), courses. Courses of 10 to 20 days, repeated two or three times a year Community practice

The course structure is how the Khavinson protocols specify these and how they are sold. No trial has compared course dosing against continuous use, or established how long the gap between courses should be.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Nothing publishedNo figure

No half-life has ever been published for any of the Russian bioregulator peptides, in people or in animals. The research behind them, mostly from one group in St Petersburg, measures effects on tissue, gene activity and lifespan. None of it measures how long the peptide stays in the body.

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Your vial size (mg)
Printed on the vial.
What you paid per vial
$
Used for cost per dose only.
Your dose (mg)
Commonly referenced range: 2 up to 5 mgCommunity practice

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

YOUR DRAW20 / 100 units
What it costs

Cartalax starts at $31.00 across 62 vendors, typically $2.10 – $4.00 per mg.

70 listings, last read Oct 24, 2026. Shipping and card fees are not included.

See all 70 listings →
07

How do you store it?

Before mixing, and after.

Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.

Unmixed lyophilized Cartalax keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Who should avoid it

Check these before anything else.
  • Pregnancy or breastfeeding
  • Any prescription medicine you take regularly, without checking for interactions first
  • Anyone who wants established safety data, because none exists for this compound in humans

Stop and get help

These are emergencies. Seek care.
  • Spreading hives, swelling of the face or throat, or trouble breathing, which can happen with any injection and is a medical emergency
  • Redness, heat, or pus at the injection site, which can signal infection
  • Any severe or unexpected symptom
  • Anything unusual, since there is no known safety profile to compare it against

Common effects

Expected, and usually mild.
  • Little human evidence.
  • Redness, soreness, or a small bump at the injection site
  • Beyond the above, unknown. There is no reliable human data on what this compound commonly causes

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Cartalax approved?

And where the numbers on this page come from.

No. Cartalax is not approved for any use, anywhere. It is sold labeled for laboratory research only, and there is no legal route to buy it for human use.

  • Approval status
    Research only
  • Route
    Under the skin (subcutaneous)
  • Checked
    14 August 2026
  • Dose
    From community reports. No regulator or trial established this dose.
  • Vial size
    From what vendors typically list; not a recommendation.
  • Sources
    None traced yet.

What has happened recently

We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.

Guides for this compound

Sources

No primary source has been traced for this compound yet. Treat everything on this page as unverified until one is. How we grade evidence